Abstract
Quantitative analysis of studies examining the effect of ecstasy on short-term and working memory in the verbal and visuo-spatial domain was undertaken. Thirty verbal short-term memory, 22 verbal working memory, 12 visuospatial short-term memory and 9 visuospatial working memory studies met inclusion criteria. Ecstasy users performed significantly worse in all memory domains, both in studies using drug-naïve controls and studies using polydrug controls. These results are consistent with previous meta-analytic findings that ecstasy use is associated with impaired short-term memory function. Lifetime ecstasy consumption predicted effect size in working memory but not in short-term memory. The current meta-analysis adds to the literature by showing that ecstasy use in humans is also associated with impaired working memory, and that this impairment is related to total lifetime ecstasy consumption. These findings highlight the long-term, cumulative behavioral consequences associated with ecstasy use in humans.
Similar content being viewed by others
References
Back-Madruga, C., Boone, K. B., Chang, L., Grob, C. S., Lee, A., Nations, H., et al. (2003). Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users. Clinical Neuropsychologist, 17, 446–459.
Bedi, G., & Redman, J. (2008). Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds. Psychological Medicine, 38, 1319–1330.
Bhattachary, S., & Powell, J. H. (2001). Recreational use of 3, 4-methylenedioxymethamphetamine (MDMA) or ‘ecstasy’: evidence for cognitive impairment. Psychological Medicine, 31, 647–658.
Cantor, J., Engle, R. W., & Hamilton, G. (1991). Short-term memory, working memory, and verbal abilities: how do they relate? Intelligence, 15, 229–246.
Capela, J. P., Carmo, H., Femião, F., Bastos, M. L., Meisel, A., & Carvalho, F. (2009). Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Molecular Neurobiology, 39, 210–271.
Cohen, J. (1969). Statistical power analysis for the behavioral sciences. NY: Academic Press.
Cole, J. C., Michailidou, K., Jerome, L., & Sumnall, H. R. (2006). The effects of stereotype threat on cognitive function in ecstasy users. Journal of Psychopharmacology, 20, 518–525.
Conway, A. R. A., Cowan, N., Bunting, M. F., Therriault, D. J., & Minkoff, S. R. B. (2002). A latent variable analysis of working memory capacity, short-term memory capacity, processing speed, and general fluid intelligence. Intelligence, 30, 163–183.
Croft, R. J., Mackay, A. J., Mills, A. T. D., & Gruzelier, J. G. H. (2001). The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology, 153, 373–379.
Curran, H. V. (2000). Is MDMA (‘Ecstasy’) neurotoxic in humans? An overview of evidence and of methodological problems in research. Neuropsychobiology, 42, 34–41.
Dafters, R. I. (2006). Chronic ecstasy (MDMA) use is associated with deficits in taskswitching but not inhibition or memory updating executive functions. Drug and Alcohol Dependence, 83, 181–184.
Daumann, J., Schnitker, R., Weidemann, J., Schnell, K., Thron, A., & Gouzoulis-Mayfrank, E. (2003). Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users. NeuroReport, 14, 1983–1987.
de Sola, S., Tarancón, T., Peña-Casanova, J., Espadaler, J. M., Langohr, K., Poudevida, S., et al. (2008). Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study. Psychopharmacology, 200, 425–437.
de Sola Llopis, S., Miguelez-Pan, M., Peña-Casanova, J., Poudevida, S., Farré, M., Pacifici, R., et al. (2008). Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. Journal of Psychopharmacology, 22, 498–510.
D’Esposito, M., Postle, B. R., Ballard, D., & Lease, J. (1999). Maintenance versus manipulation of information held in working memory: An event-related fMRI study. Brain and Cognition, 41, 66–86.
Della Sala, S., Gray, C., Baddeley, A., Allamano, N., & Wilson, L. (1999). Pattern span: A tool for unwelding visuo-spatial memory. Neuropsychologia, 37, 1189–1199.
Engle, R. W., Tuholski, S. W., Laughlin, J. E., & Conway, A. R. A. (1999). Working memory, short-term memory, and general fluid intelligence: a latent-variable approach. Journal of Experimental Psychology: General, 128, 309–331.
Fisk, J. E., & Montgomery, C. (2009). Evidence for selective executive function deficits in ecstasy/polydrug users. Journal of Psychopharmacology, 23, 40–50.
Fisk, J. E., Montgomery, C., Murphy, P., & Wareing, M. (2004). Evidence for executive deficits among users of MDMA (Ecstasy). British Journal of Psychology, 95, 457–466.
Fox, H. C., Parrott, A. C., & Turner, J. J. D. (2001). Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug. Journal of Psychopharmacology, 15, 273–281.
Fox, H. C., McLean, A., Turner, J. J. D., Parrott, A. C., Rogers, R., & Sahakian, B. J. (2002). Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA (“ecstasy”) polydrug users. Psychopharmacology, 162, 203–214.
Golding, J. F., Groome, D. H., Rycroft, N., & Denton, Z. (2007). Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls. The American Journal of Drug and Alcohol Abuse, 33, 301–307.
Gouzoulis-Mayfrank, E., Daumann, J., Tuchtenhagen, F., Pelz, S., Becker, S., Kunert, H-J., et al. (2000). Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). Journal of Neurology, Neurosurgery & Psychiatry, 68, 719–725.
Gouzoulis-Mayfrank, E., Thimm, B., Rezk, M., Hensen, G., & Daumann, J. (2003). Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 27, 819–827.
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, I. (2003). The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, “Ecstasy”). Pharmacological Reviews, 55, 463–508.
Halpern, J. H., Pope, H. G., Jr., Sherwood, A. R., Barry, S., Hudson, J. I., & Yurgelun-Todd, D. (2004). Residual neuropsychological effects of illicit 3, 4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug and Alcohol Dependence, 75, 135–147.
Hanson, K. L., & Luciana, M. (2004). Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use. Psychological Medicine, 34, 229–246.
Hatzidimitriou, G., McCann, U. D., & Ricaurte, G. A. (1999). Altered serotonin innervation patterns in the forebrain of monkeys treated with (6)3, 4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. The Journal of Neuroscience, 19, 5096–5107.
Heffernan, T., Jarvis, H., Rodgers, J., Scholey, A. B., & Ling, J. (2001). Prospective memory, everyday cognitive failure and central executive function in recreational users of ecstasy. Human Psychopharmacology: Clinical and Experimental, 16(8), 607–612.
Kalechstein, A. D., De La Garza, R., II, Mahoney, J. J., III, Fantegrossi, W. E., & Newton, T. F. (2007). MDMA use and neurocognition: a meta-analytic review. Psychopharmacology, 189, 531–537.
Kessels, R. P. C., van den Berg, E., Ruis, C., & Brands, A. M. A. (2008). The backward span of the Corsi block-tapping task and its association with the WAIS-III digit span. Assessment, 15, 426–434.
Kirchner, W. K. (1958). Age differences in short-term retention of rapidly changing information. Journal of Experimental Psychology, 55, 352–358.
Lamers, C. T. J., Bechara, A., Rizzo, M., & Ramaekers, J. G. (2006). Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls. Journal of Psychopharmacology, 20, 302–311.
Lau, J., Ioannidis, J. P. A., & Schmid, C. H. (1997). Quantitative synthesis in systematic reviews. Annals of Internal Medicine, 127, 820–826.
Laws, K. R., & Kokkalis, J. (2007). Ecstasy (MDMA) and memory function: a meta-analytic update. Human Psychopharmacology: Clinical and Experimental, 22, 381–388.
Lezak, M. (1995). Neuropsychological assessment (3rd ed.). New York: Oxford University Press.
Luciana, M., Collins, P. F., & Depue, R. A. (1998). Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cerebral Cortex, 8, 218–226.
Luciana, M., Burgund, E. D., Berman, M., & Hanson, K. L. (2001). Effects of tryptophan loading on verbal, spatial and affective working memory functions in healthy adults. Journal of Psychopharmacology, 15, 219–230.
McCann, U. D., Eligulashvili, V., & Ricaurte, G. A. (2000). (±)3, 4-methylenedioxymethamphetamine (‘Ecstasy’)-induced serotonin neurotoxicity: clinical studies. Neuropsychobiology, 42, 11–16.
McCann, U. D., Mertl, M., Eligulashvili, V., & Ricaurte, G. A. (1999). Cognitive performance in (±) 3, 4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study. Psychopharmacology, 143, 417–425.
McCann, U. D., Peterson, S. C., & Ricaurte, G. A. (2007). The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users. Neuropsychopharmacology, 32, 1695–1706.
McCardle, K., Luebbers, S., Carter, J. D., Croft, R. J., & Stough, C. (2004). Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology, 173, 434–439.
Medina, K. L., Shear, P. K., & Corcoran, K. (2005). Ecstasy (MDMA) exposure and neuropsychological functioning: A polydrug perspective. Journal of the International Neuropsychological Society, 11, 753–765.
Montgomery, C., & Fisk, J. E. (2007). Everyday memory deficits in ecstasy-polydrug users. Journal of psychopharmacology, 21(7), 709–717.
Montgomery, C., & Fisk, J. E. (2008). Ecstasy-related deficits in the updating component of executive processes. Human Psychopharmacology: Clinical and Experimental, 23, 495–511.
Montgomery, C., Fisk, J. E., Newcombe, R., Wareing, M., & Murphy, P. N. (2005). Syllogistic reasoning performance in MDMA (Ecstasy) users. Experimental and Clinical Psychopharmacology, 13, 137–145.
Morgan, M. J. (1998). Recreational use of ‘ecstasy’ (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology, 19, 252–264.
Morgan, M. J. (1999). Memory deficits associated with recreational use of “ecstasy” (MDMA). Psychopharmacology, 141, 30–36.
Morgan, M. J. (2000). Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology, 153, 230–248.
Owen, A. M. (1997). The functional organization of working memory processes within human lateral frontal cortex: the contribution of functional neuroimaging. European Journal of Neuroscience, 9, 1329–1339.
Park, D. C., Lautenschlager, G., Hedden, T., Davidson, N. S., Smith, A. D., & Smith, P. K. (2002). Models of visuospatial and verbal memory across the adult life span. Psychology and Aging, 17(2), 299–320.
Parrott, A. C., Lees, A., Garnham, N. J., Jones, M., & Wesnes, K. (1998). Cognitive performance in recreational users of MDMA or ‘ecstasy’: evidence for memory deficits. Journal of Psychopharmacology, 12, 79–83.
Pereira, A. P. A. (2007). Assessment of memory in rehabilitation counselling. Journal of Rehabilitation, 73, 15–25.
Pollack, I., Johnson, L. B., & Knaff, P. R. (1959). Running memory span. Journal of Experimental Psychology, 57, 137–146.
Quednow, B. B., Jessen, F., Kühn, K.-U., Maier, W., Daum, I., & Wagner, M. (2006). Memory deficits in abstinent MDMA (ecstasy) users: Neuropsychological evidence of frontal dysfunction. Journal of Psychopharmacology, 20, 373–384.
Reay, J. L., Hamilton, C., Kennedy, D. O., & Scholey, A. B. (2006). MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes. Journal of Psychopharmacology, 20, 385–388.
Reneman, L., Booij, J., Schmand, B., van den Brink, W., & Gunning, B. (2000). Memory disturbances in “Ecstasy” users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology, 148, 322–324.
Reneman, L., Lavalaye, J., Schmand, B., de Wolff, F., van den Brink, W., den Heeten, G., et al. (2001a). Cortical serotonin transporter density and verbal memory in individuals who stopped using 3, 4-methylenedioxymethamphetamine (MDMA or “Ecstasy”): Preliminary findings. Archives of General Psychiatry, 58, 901–906.
Reneman, L., Majoie, C. B. L. M., Schmand, B., van den Brink, W., & den Heeten, G. J. (2001b). Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report. Biological Psychiatry, 50, 550–554.
Reneman, L., Schilt, T., de Win, M. M., Booij, J., Schmand, B., van den Brink, W., et al. (2006). Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. Journal of Psychopharmacology, 20, 389–399.
Repovs, G., & Baddeley, A. (2006). The multi-component model of working memory: explorations in experimental cognitive psychology. Neuroscience, 139, 5–21.
Richardson, J. T. E. (2007). Measures of short-term memory: a historical review. Cortex, 43, 635–650.
Rodgers, J. (2000). Cognitive performance amongst recreational users of “ecstasy”. Psychopharmacology, 151, 19–24.
Roiser, J. P., Rogers, R. D., & Sahakian, B. J. (2007). Neuropsychological function in ecstasy users: a study controlling for polydrug use. Psychopharmacology, 189, 505–516.
Rosenthal, R. (1979). The “file drawer problem” and tolerance for null results. Psychological Bulletin, 86, 638–641.
Schifano, F., Di Furia, L., Forza, G., Minicuci, N., & Bricolo, R. (1998). MDMA (‘ecstasy’) consumption in the context of polydrug abuse: a report on 150 patients. Drug and Alcohol Dependence, 52, 85–90.
Schilt, T., De Win, M. M., Koeter, M., Jager, G., Korf, D. J., van den Brink, W., et al. (2007). Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Archives of General Psychiatry, 64, 728–736.
Thomasius, R., Zapletalova, P., Petersen, K., Buchert, R., Andresen, B., Wartberg, L., et al. (2006). Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. Journal of Psychopharmacology, 20, 211–225.
Verbaten, M. N. (2003). Specific memory deficits in ecstasy users? The results of a meta-analysis. Human Psychopharmacology: Clinical and Experimental, 18, 281–290.
Verkes, R. J., Gijsman, H. J., Pieters, M. S. M., Schoemaker, R. C., de Visser, S., Kuijpers, M., et al. (2001). Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology, 153, 196–202.
von Geusau, N. A., Stalenhoef, P., Huizinga, M., Snel, J., & Ridderinkof, K. R. (2004). Impaired executive function in male MDMA (“ecstasy”) users. Psychopharmacology, 175, 331–341.
Wager, T. D., & Smith, E. E. (2003). Neuroimaging studies of working memory: a meta-analysis. Cognitive, Affective, & Behavioral Neuroscience, 3, 255–274.
Wareing, M., Fisk, J. E., & Murphy, P. N. (2000). Working memory deficits in current and previous users of MDMA (‘ecstasy’). British Journal of Psychology, 91, 181–188.
Wareing, M., Fisk, J. E., Murphy, P., & Montgomery, C. (2004a). Verbal working memory deficits in current and previous users of MDMA. Human Psychopharmacology: Clinical and Experimental, 19, 225–234.
Wareing, M., Murphy, P. N., & Fisk, J. E. (2004b). Visuospatial memory impairments in users of MDMA (‘ecstasy’). Psychopharmacology, 173, 391–397.
Wareing, M., Fisk, J. E., Murphy, P., & Montgomery, C. (2005). Visuo-spatial working memory deficits in current and former users of MDMA (‘ecstasy’). Human Psychopharmacology: Clinical and Experimental, 20, 115–123.
Wareing, M., Fisk, J. E., Montgomery, C., Murphy, P. N., & Chandler, M. D. (2007). Information processing speed in ecstasy (MDMA) users. Human Psychopharmacology: Clinical and Experimental, 22, 81–88.
Yip, J. T. H., & Lee, T. M. C. (2005). Effect of ecstasy use on neuropsychological function: a study in Hong Kong. Psychopharmacology, 179, 620–628.
Zakzanis, K. K., & Young, D. A. (2001). Memory impairment in abstinent MDMA (“Ecstasy”) users: a longitudinal investigation. Neurology, 56, 966–969.
Zakzanis, K. K., & Campbell, Z. (2006). Memory impairment in now abstinent MDMA users and continued users: a longitudinal follow-up. Neurology, 66(5), 740–741.
Zakzanis, K. K., Young, D. A., & Campbell, Z. (2003). Prospective memory impairment in abstinent MDMA (“Ecstasy”) users. Cognitive Neuropsychiatry, 8(2), 141–153.
Zakzanis, K. K., Campbell, Z., & Jovanovski, D. (2007). The neuropsychology of ecstasy (MDMA) use: a quantitative review. Human Psychopharmacology: Clinical and Experimental, 22, 427–435.
Zaninotto, A. L. C., Bueno, O. F. A., Pradella-Hallinan, M., Tufik, S., Rusted, J., Stough, C., et al. (2009). Acute cognitive effects of donepezil in young, healthy volunteers. Human Psychopharmacology: Clinical and Experimental, 24, 453–464.
Acknowledgements
This study was supported by an Australian Postgraduate Award provided to C. Nulsen.
Disclosure
The authors declare that no conflicts of interest are associated with the preparation of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nulsen, C.E., Fox, A.M. & Hammond, G.R. Differential Effects of Ecstasy on Short-Term and Working Memory: A Meta-Analysis. Neuropsychol Rev 20, 21–32 (2010). https://doi.org/10.1007/s11065-009-9124-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11065-009-9124-z